衰老细胞作为抗瘤免疫的恒温器
Luis I Prieto1, Ines Sturmlechner2, Jörg J Goronzy2,3,4
1Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Science translational medicine
|June 7, 2023
概括
利用衰老细胞提供了一个潜在的策略来增强抗瘤免疫力. 这种方法的方法.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞衰老 细胞衰老
背景情况:
- 细胞衰老,一种不可逆转的细胞循环停止状态,在癌症中起着复杂的作用.
- 衰老细胞可以表现出支持瘤的和抗瘤的特性,这取决于背景.
研究的目的:
- 探索利用衰老细胞的免疫性质来增强抗癌免疫反应的潜力.
- 了解衰老细胞在调节抗瘤免疫中的上下文依赖性.
主要方法:
- 在临床前癌症模型中研究衰老细胞的免疫调节作用.
- 分析瘤微环境和免疫细胞透,以应对衰老细胞诱导.
主要成果:
- 衰老细胞可以引起免疫反应,可以用来增强抗瘤免疫力.
- 向衰老细胞的有效性高度依赖于特定的瘤类型及其微观环境.
结论:
- 向衰老细胞是癌症免疫疗法的一个有希望的,尽管特定于环境的途径.
- 需要进一步的研究来界定精确的机制,并优化临床应用的策略.
相关概念视频
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Cytotoxic T Cells-mediated Immune Response
1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Multipotency of Hematopoietic Stem Cells
3.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.2K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575


